Ultragenyx (NASDAQ:RARE) Q4 results:
Revenue: $35.6M (+118%); product sales: $7.2M (+107%).
Net loss: ($93.8M); loss/share: ($1.62).
2020 guidance: Crysvita revenue: $125M – 140M.
https://seekingalpha.com/news/3541919-ultragenyx-q4-revenue-up-118
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.